Future Medicine Co., Ltd. (XKON: 341170)
1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Statistics
Total Valuation
Future Medicine has a market cap or net worth of KRW 17.62 billion.
Market Cap | 17.62B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Future Medicine has 9.28 million shares outstanding.
Shares Outstanding | 9.28M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +35.88% |
Owned by Insiders (%) | 15.35% |
Owned by Institutions (%) | 3.90% |
Float | 7.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 15.51 |
PB Ratio | 2.70 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.62, with a Debt / Equity ratio of 3.47.
Current Ratio | 9.62 |
Quick Ratio | 9.08 |
Debt / Equity | 3.47 |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | -4.55 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Future Medicine had revenue of KRW 1.00 billion and -13.37 billion in losses. Loss per share was -1,637.42.
Revenue | 1.00B |
Gross Profit | 1.00B |
Operating Income | -7.09B |
Pretax Income | -13.37B |
Net Income | -13.37B |
EBITDA | -6.64B |
EBIT | -7.09B |
Loss Per Share | -1,637.42 |
Balance Sheet
The company has 5.41 billion in cash and 226.27 million in debt, giving a net cash position of 5.18 billion or 558.86 per share.
Cash & Cash Equivalents | 5.41B |
Total Debt | 226.27M |
Net Cash | 5.18B |
Net Cash Per Share | 558.86 |
Equity (Book Value) | 6.52B |
Book Value Per Share | 703.11 |
Working Capital | 5.21B |
Cash Flow
In the last 12 months, operating cash flow was -7.09 billion and capital expenditures -110.72 million, giving a free cash flow of -7.20 billion.
Operating Cash Flow | -7.09B |
Capital Expenditures | -110.72M |
Free Cash Flow | -7.20B |
FCF Per Share | -776.78 |
Margins
Gross Margin | 100.00% |
Operating Margin | -708.92% |
Pretax Margin | -1,336.67% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -720.50% |
Dividends & Yields
Future Medicine does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -86.18% |
FCF Yield | -40.88% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |